Mechanisms of small molecule gene transcriptional regulators
小分子基因转录调控机制
基本信息
- 批准号:10242743
- 负责人:
- 金额:$ 37.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAddressBCL3 geneBindingBiochemicalBiophysicsBromodomainCalorimetryCell NucleusCell ProliferationCell physiologyClinicalComplexCrystallizationDNADataDevelopmentDiseaseEGR2 geneElementsEnhancersEnvironmentEpigenetic ProcessFamilyFibrosisFutureGTP-Binding ProteinsGene Expression RegulationGeneticGenetic TranscriptionGoalsHSF1Histone DeacetylaseHistone Deacetylase InhibitorImmediate-Early GenesIn VitroInflammatoryInterleukin-6JUN geneKnockout MiceLuciferasesMalignant NeoplasmsMediatingMolecular Mechanisms of ActionMolecular TargetMyofibroblastNeoplasm MetastasisNuclear ProteinOxidation-ReductionPaperPathway interactionsPharmacologyPhenotypePlayProteinsPublishingPulmonary FibrosisReporterRoleScanningSclerodermaSerumSerum Response FactorSignal TransductionSmall Interfering RNASpeedStructureTherapeuticTitrationsToll-like receptorsTranscriptional RegulationVinculinWorkcancer cellcell motilityconnective tissue growth factorin vivoinhibitor/antagonistmouse modelmyocardinnovelnovel therapeuticsp65preventpromoterrhosmall moleculetooltranscription factor
项目摘要
Summary
Gene transcription signaling through RhoA- and actin-regulated transcription factors plays a critical role in
diverse diseases such as cancer and fibrosis. Transcription factors downstream of RhoA and actin, serum
response factor (SRF) and myocardin-related transcription factor (MRTF) controls cell proliferation, cancer cell
migration and metastasis and the myofibroblast activation. We identified MRTF-pathway inhibitor compounds
(e.g. CCG-1423 and CCG-203971) and recently identified the redox-sensitive nuclear protein pirin as a
molecular target. This reveals pirin as a regulator of MRTF/SRF- and NFkB-regulated gene transcription
providing a novel dual inhibitor mechanism for our CCG compounds relevant to cancer and fibrotic diseases
by blocking both inflammatory and pro-fibrotic/proliferative signals.
The overarching goal of this work is to explore the role of pirin and the mechanisms of CCG compounds in
regulating gene transcription. The specific goals of this renewal application are to explore pirin’s actions on gene
transcription regulated by RhoA/MRTF/SRF and NFB and to define the pirin-dependent and potentially pirin-
independent molecular mechanisms of action of the CCG compounds.
To accomplish this goal, we will address the following specific aims:
Aim 1 Elucidate biochemically, pirin’s interactions with MRTF, SRF, p65, and their DNA complexes with a focus
on the role of pirin redox state and the effects of pirin-modulating compounds on these mechanisms.
Aim 2 Assess the role of pirin and the effects of CCG compounds in pro-fibrotic and inflammatory gene
transcription mediated by MRTF/SRF, TGF-, Toll-like receptors (TLRs), and NFB by use of a novel pirin knock-
out mouse model.
Impact - Successful completion of these aims will reveal mechanisms and scope of gene regulation by pirin and
how this may be influenced by the redox environment. It will also provide a mechanistic framework for future
development of CCG compounds for clinical use in cancer and fibrotic diseases.
概括
通过 RhoA 和肌动蛋白调节转录因子的基因转录信号在
癌症和纤维化等多种疾病。 RhoA 和肌动蛋白下游转录因子、血清
反应因子(SRF)和心肌素相关转录因子(MRTF)控制细胞增殖、癌细胞
迁移和转移以及肌成纤维细胞激活。我们鉴定了 MRTF 通路抑制剂化合物
(例如 CCG-1423 和 CCG-203971),最近鉴定出氧化还原敏感核蛋白 Pirin 作为
分子靶标。这揭示了 Pirin 作为 MRTF/SRF 和 NFkB 调节基因转录的调节剂
为我们与癌症和纤维化疾病相关的 CCG 化合物提供新型双重抑制剂机制
通过阻断炎症和促纤维化/增殖信号。
这项工作的总体目标是探索 Pirin 的作用以及 CCG 化合物在
调节基因转录。该更新应用程序的具体目标是探索皮林对基因的作用
转录受 RhoA/MRTF/SRF 和 NF+B 调节,并定义了 pirin 依赖性和潜在的 pirin-
CCG 化合物的独立分子作用机制。
为了实现这一目标,我们将实现以下具体目标:
目标 1 重点阐明 pirin 与 MRTF、SRF、p65 及其 DNA 复合物的生化相互作用
关于皮林氧化还原态的作用以及皮林调节化合物对这些机制的影响。
目标 2 评估 Pirin 的作用以及 CCG 化合物对促纤维化和炎症基因的影响
MRTF/SRF、TGF-β、Toll 样受体 (TLR) 和 NFβB 通过使用新型 Pirin 敲入介导的转录
出鼠标模型。
影响 - 成功完成这些目标将揭示皮林和基因调控的机制和范围
这如何受到氧化还原环境的影响。它还将为未来提供一个机制框架
开发用于癌症和纤维化疾病临床应用的 CCG 化合物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD R NEUBIG其他文献
RICHARD R NEUBIG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD R NEUBIG', 18)}}的其他基金
Mechanisms of small molecule gene transcriptional regulators
小分子基因转录调控机制
- 批准号:
10436339 - 财政年份:2016
- 资助金额:
$ 37.58万 - 项目类别:
Mechanisms of small molecule gene transcriptional regulators
小分子基因转录调控机制
- 批准号:
9980930 - 财政年份:2016
- 资助金额:
$ 37.58万 - 项目类别:
Small molecule stabilizers of RGS protein expression
RGS蛋白表达的小分子稳定剂
- 批准号:
8894023 - 财政年份:2014
- 资助金额:
$ 37.58万 - 项目类别:
Integrative Pharmacological Sciences Training Program (IPSTP)
综合药理学科学培训计划(IPSTP)
- 批准号:
9303388 - 财政年份:2011
- 资助金额:
$ 37.58万 - 项目类别:
Integrative Pharmacological Sciences Training Program (IPSTP)
综合药理学科学培训计划(IPSTP)
- 批准号:
9149647 - 财政年份:2011
- 资助金额:
$ 37.58万 - 项目类别:
Design of Small Molecules Acting at Regulators of G Protein Signaling
作用于 G 蛋白信号传导调节器的小分子的设计
- 批准号:
8117015 - 财政年份:2007
- 资助金额:
$ 37.58万 - 项目类别:
Design of Small Molecules Acting at Regulators of G Protein Signaling
作用于 G 蛋白信号传导调节器的小分子的设计
- 批准号:
7371562 - 财政年份:2007
- 资助金额:
$ 37.58万 - 项目类别:
Design of Small Molecules Acting at Regulators of G Protein Signaling
作用于 G 蛋白信号传导调节器的小分子的设计
- 批准号:
7667819 - 财政年份:2007
- 资助金额:
$ 37.58万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
Research Grant














{{item.name}}会员




